CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 CNY | +0.54% |
|
+5.10% | -26.68% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chengdu Huasun Technology Group Co Ltd, formerly Chengdu Taihe Health Technology Group Inc., Ltd., is principally engaged in manufacture and distribution of Chinese medicines and Western medicines, fabrication and installation services of steel structures, as well as production and sale of bio-engineering products. The Company primarily provides Chinese medicines, Western medicines, biological drugs, veterinary drugs and veterinary biological vaccines, as well as modern steel structures. Its pharmaceutical products include oral liquid, capsules, biological products and veterinary drugs, among others. The Company operates its businesses primarily in the China domestic market, with Sichuan province as its main market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -26.68% | 321M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 000790 Stock
- News Chengdu huasun technology group Inc. , LTD.
- Chengdu Huasun Technology to Construct Drug Ingredient Plant for 480 Million Yuan
